Bloomage Biotechnology Corp Ltd (688363) - Total Assets
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) holds total assets worth CN¥8.75 Billion CNY (≈ $1.28 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 688363 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Bloomage Biotechnology Corp Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's total assets have evolved over time, based on quarterly financial data. Check how high is Bloomage Biotechnology Corp Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bloomage Biotechnology Corp Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Bloomage Biotechnology Corp Ltd's total assets of CN¥8.75 Billion consist of 32.0% current assets and 68.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.5% |
| Accounts Receivable | CN¥564.47 Million | 6.5% |
| Inventory | CN¥980.62 Million | 11.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥517.62 Million | 6.0% |
| Goodwill | CN¥177.62 Million | 2.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Bloomage Biotechnology Corp Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bloomage Biotechnology Corp Ltd's current assets represent 32.0% of total assets in 2025, a decrease from 54.7% in 2012.
- Cash Position: Cash and equivalents constituted 11.5% of total assets in 2025, down from 25.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 11.3% of total assets.
Bloomage Biotechnology Corp Ltd Competitors by Total Assets
Key competitors of Bloomage Biotechnology Corp Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Peric Special Gases Co. Ltd. A
SHG:688146
|
China | CN¥7.26 Billion |
|
NINGBO SHANSHAN GDR/A
F:OJ8
|
Germany | €45.88 Billion |
|
Hengyi Petrochemical Co Ltd
SHE:000703
|
China | CN¥111.51 Billion |
|
Suzhou Crystal Clear Chemical Co Ltd
SHE:300655
|
China | CN¥5.29 Billion |
|
Jiangsu Cnano Technology Co Ltd
SHG:688116
|
China | CN¥5.83 Billion |
|
Qingdao Gon Technology Co Ltd
SHE:002768
|
China | CN¥21.26 Billion |
|
5N Plus Inc.
TO:VNP
|
Canada | CA$519.27 Million |
|
Suzhou Shihua New Material Technology Co Ltd
SHG:688093
|
China | CN¥2.99 Billion |
Bloomage Biotechnology Corp Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.36 | 2.37 | 4.05 |
| Quick Ratio | 1.59 | 1.27 | 3.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.65 Billion | CN¥1.53 Billion | CN¥2.86 Billion |
Bloomage Biotechnology Corp Ltd - Advanced Valuation Insights
This section examines the relationship between Bloomage Biotechnology Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.79 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | CN¥8.69 Billion |
| Market Capitalization | $2.50 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bloomage Biotechnology Corp Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bloomage Biotechnology Corp Ltd's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below shows the annual total assets of Bloomage Biotechnology Corp Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
+0.41% |
| 2024-12-31 | CN¥8.66 Billion ≈ $1.27 Billion |
+2.20% |
| 2023-12-31 | CN¥8.47 Billion ≈ $1.24 Billion |
-2.44% |
| 2022-12-31 | CN¥8.68 Billion ≈ $1.27 Billion |
+15.70% |
| 2021-12-31 | CN¥7.50 Billion ≈ $1.10 Billion |
+31.26% |
| 2020-12-31 | CN¥5.72 Billion ≈ $836.56 Million |
+14.99% |
| 2019-12-31 | CN¥4.97 Billion ≈ $727.51 Million |
+140.06% |
| 2018-12-31 | CN¥2.07 Billion ≈ $303.05 Million |
+9.98% |
| 2017-12-31 | CN¥1.88 Billion ≈ $275.55 Million |
+11.81% |
| 2016-12-31 | CN¥1.68 Billion ≈ $246.45 Million |
-23.42% |
| 2015-12-31 | CN¥2.20 Billion ≈ $321.81 Million |
+127.79% |
| 2014-12-31 | CN¥965.44 Million ≈ $141.27 Million |
+25.66% |
| 2013-12-31 | CN¥768.31 Million ≈ $112.43 Million |
+62.00% |
| 2012-12-31 | CN¥474.26 Million ≈ $69.40 Million |
-- |
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more